DECIDE-AI: will it make the development of artificial intelligence-based clinical decision support systems more robust?
New guidelines aim to improve early clinical testing of AI-based systems.
ICMJE recommendations update: what you need to know
Find out what’s new in the latest 2022 update to the ICMJE recommendations.
Data sharing and reporting still suboptimal in vaccine trials
A recent analysis of randomised controlled vaccine trials suggests there are still improvements to be made.
Language-generating AI in science: transformational or deformational?
Read about the potential impacts of large language models, and what needs to happen to ensure they benefit, rather than hinder, scientific fields.
Are we still missing the mark with randomised controlled trial abstracts?
Adherence to the Consolidated Standards of Reporting Trials for Abstracts continues to be inadequate, nearly 15 years after their release.
Addressing race and ethnicity in medical literature
Learn about the current failings in race and ethnicity reporting in regulatory documents and medical literature and how they can be overcome.
CHEERS 2022 statement: reporting guidance for health economic evaluations gets a makeover
Read about the new 28-item checklist developed to aid decision-making in health economic evaluations.
GPP 2022: latest guidelines for company-sponsored publications are out now
Find out what’s new in the eagerly awaited 2022 update to the Good Publication Practice guidelines published in August.
GRReaT expectations: are editable templates the future of manuscript writing?
Read about EQUATOR Network’s updated GoodReports website, new downloadable and editable article templates and a call for researchers to help test whether the templates improve research reporting.
What counts as a ‘substantial contribution’ to industry-sponsored research?
Recommendations from the ISMPP Authorship Task Force aim to clarify ICMJE guidelines on authorship selection criteria.
New STROBE-MR guideline lights the way for Mendelian randomisation studies
Find out what’s in the new STROBE-MR checklist for reporting of observational epidemiology studies using Mendelian randomisation.
Considering sex and gender in medical research: insights from the lead author of the SAGER guidelines
Read Shirin Heidari’s thoughts on the importance of incorporating sex and gender dimensions in clinical research design and reporting.
Quantifying authorship in clinical trial publications – a new algorithm
Learn about a new decision support tool developed to supplement the ICMJE criteria and GPP3 guidelines.
How to preprint properly: updated guidance from the ICMJE
Find out more about ICMJE’s latest recommendations on the use of preprints in scientific publishing.
Meeting report: summary of Day 2 of the 2022 ISMPP European Meeting
Missed the meeting? Read our report to get up to speed!
Meeting report: summary of Day 1 of the 2022 ISMPP European Meeting
Missed the meeting? Read our report to get up to speed!